UCSF Researchers Identify Gut Molecular Pathway That Shuts Down Appetite During Parasitic Infections

UCSF researchers uncover the molecular pathway between the gut and brain that triggers appetite loss during parasitic infections and chronic illness.

By: AXL Media

Published: Mar 28, 2026, 5:28 AM EDT

Source: Information for this report was sourced from ScienceDaily

The Biological Logic of Infection Induced Fasting

The sudden disappearance of appetite during a severe illness is a near universal human experience, yet the precise mechanics of this behavioral shift have long eluded the scientific community. New research published in the journal Nature has finally mapped the specific communication lines that allow the digestive system to recruit the nervous system during an immune challenge. This process is not merely a side effect of being unwell, but rather an elegant molecular logic designed to alter host behavior in response to external threats. According to David Julius, a professor at UCSF and Nobel laureate, the study highlights how the immune system actively signals the brain to shut down the drive to eat when it detects the presence of parasites.

Crosstalk Between Rare Intestinal Detectors

At the center of this discovery are two specialized and relatively uncommon types of cells residing within the gut lining. Tuft cells serve as the primary detectors, capable of sensing the biological signatures of parasitic worms, while enterochromaffin cells act as signaling hubs that stimulate nerve pathways. The research demonstrates a previously unknown interaction where tuft cells, upon detecting a compound known as succinate from parasites, release acetylcholine to communicate with their neighbors. This chemical handoff triggers the enterochromaffin cells to release serotonin, which then activates the vagus nerve to carry a "stop eating" message directly to the brain.

The Multi Phase Release of Chemical Signals

One of the more perplexing aspects of illness is the delay between the initial infection and the subsequent loss of interest in food. The UCSF team found that this timing is controlled by a two phase release of acetylcholine from the tuft cells. Initially, the cells provide a short burst of signaling that is insufficient to fully suppress appetite. However, as the immune response intensifies and the number of tuft cells increases, they begin a sustained and much stronger release of the chemical. According to Koki Tohara, a postdoctoral researcher, this secondary phase is what ultimately convinces the brain that the threat is persistent, leading to a profound change in eating habits.